- Contact Us
- Our Solutions
- Healthcare Professionals
- Patients & Caregivers
- About Nuwellis
By Laura Serrano / January 27, 2022
“In the U.S., it’s common to see patients who are pushed out of the hospital after a few days only to return with the same issues within a few weeks, whereas patients in other countries may stay in the hospital for weeks on end until a solution is identified,” said Laurent Duhoux, Vice President of International Business Development.
We know each patient and situation is unique, which is why we believe so strongly that each care plan should be personalized. Our mission is to transform the lives of patients suffering from fluid overload, and we’re constantly striving to meet that mission by expanding access to our lifesaving Aquadex therapy – and that means access beyond U.S. borders.
“Our goal, is with more access to ultrafiltration, more patients can be treated quickly and effectively, reducing the burden on patients and health systems around the world,” said Laurent Duhoux.
As Nuwellis expands its business, healthcare providers around the world have expressed excitement about offering their patients an alternative to traditional diuretics.
“When we start business in a new country, I’m often there when the first patient is treated with Aquadex,” said Duhoux.
“Working with doctors and nurses to not only help them realize the benefits of our therapy but also improving their patients’ lives and watching those transformations firsthand, is incredibly rewarding.”